NCT02096627

Brief Summary

In this project, the investigators aim to compare the safety, efficacy, and predictability outcomes of conventional CEIOL surgery to Femtosecond-laser-assisted CEIOL (FLACS) in an effort to improve cataract surgery outcomes. The investigators hypothesis is that FLACS may lead to preservation of endothelial cells compared to conventional CE IOL.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
154

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2014

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 26, 2014

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2014

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
Last Updated

November 16, 2018

Status Verified

November 1, 2018

Enrollment Period

4.5 years

First QC Date

March 16, 2014

Last Update Submit

November 15, 2018

Conditions

Keywords

Cataract, femtosecond laser, FLACS

Outcome Measures

Primary Outcomes (1)

  • endothelial cell density three months after conventional CEIOL or FLACS compared to baseline

    endothelial cell density will be compared at baseline and three months after a patient undergoes FLACS or Conventional CE IOL to see which technique causes less endothelial cell loss.

    up to 2 years

Study Arms (2)

conventional

Patients who undergo routine cataract surgery using conventional phacoemulsification technique

FLACS

Patients who undergo femtosecond laser assisted cataract surgery

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who present to our center with visually significant cataract and who may benefit from cataract surgery

You may qualify if:

  • Patients older than 18 years of age
  • Ability to understand and sign an informed consent
  • Visually significant cataract eligible to undergo cataract extraction by phacoemulsification with primary intraocular lens implantation in at least 1 eye
  • Ability and commitment to follow up for 18 months after surgery
  • No other ocular pathology and no previous/concurrent surgery

You may not qualify if:

  • Any other ocular pathology that may affect best-corrected visual acuity
  • Previous or concurrent ocular surgery
  • Subjects who are pregnant, lactating, or planning to be pregnant during the course of the study.
  • Patients with keratoconus or keratectasia
  • Patients who are blind on one eye

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins University

Baltimore, Maryland, 21044, United States

Location

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • yassine daoud, md

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2014

First Posted

March 26, 2014

Study Start

May 1, 2014

Primary Completion

November 1, 2018

Study Completion

November 1, 2018

Last Updated

November 16, 2018

Record last verified: 2018-11

Locations